HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R D Williams Selected Research

R D Williams Research Topics

Disease

1Cardiovascular Diseases (Cardiovascular Disease)
12/2016
1Squamous Cell Carcinoma of Head and Neck
11/2011
1Glaucoma
10/2008
1Ocular Hypertension (Glaucoma, Suspect)
10/2008
1Schizophrenia (Dementia Praecox)
05/2008
1Carcinogenesis
07/2003
1Epidermal Cyst (Sebaceous Cyst)
12/2001
1Carcinoma (Carcinomatosis)
10/2001
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2001
1Neoplasm Metastasis (Metastasis)
09/2000
1Prostatic Neoplasms (Prostate Cancer)
09/2000
1Neoplasms (Cancer)
09/2000
1Pain (Aches)
09/2000
1Alzheimer Disease (Alzheimer's Disease)
03/2000
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2000

Drug/Important Bio-Agent (IBA)

1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2016
1Pemetrexed (MTA)FDA Link
11/2011
1Bimatoprost (Lumigan)FDA Link
10/2008
1Cyclic NucleotidesIBA
05/2008
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2008
1Paired Box Transcription Factors (Pax Transcription Factors)IBA
07/2003
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
12/2001
1Transforming Growth Factor beta (TGF-beta)IBA
10/2001
1Amino AcidsFDA Link
10/2001
1Glucose (Dextrose)FDA LinkGeneric
10/2001
1LipidsIBA
10/2001
1Nucleic AcidsIBA
10/2001
1PesticidesIBA
10/2001
1OrganophosphatesIBA
10/2001
1isofenphosIBA
10/2001
1Organophosphonates (Phosphonates)IBA
09/2000
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2000
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
09/2000
1CytokinesIBA
09/2000
1samarium Sm-153 lexidronam (Quadramet)FDA Link
09/2000
1Annexin A5IBA
09/2000
1CaspasesIBA
09/2000
1Caspase 8 (Caspase-8)IBA
09/2000
1TNF-Related Apoptosis-Inducing LigandIBA
09/2000
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2000

Therapy/Procedure

1Therapeutics
11/2011
1Chemoradiotherapy
11/2011
1Induction Chemotherapy
11/2011
1Aftercare (After-Treatment)
09/2000
1Activities of Daily Living (ADL)
09/2000